Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: To study the effect of disease remission on quality of life and organ damage in patients with systemic lupus erythematosus.
Methods: Consecutive patients who fulfilled the ACR classification for SLE were recruited from our lupus out-patient clinics. Their remission status was determined according to the European consensus (DORIS definition): (1) Complete remission (clinical SLEDAI=0, serology inactive); and (2) Clinical remission (clinical SLEDAI=0, serology active). These two categories were further divided into those who required ongoing immunosuppressive treatment (prednisone ≤5mg/d or other immunosuppressive agents) and who did not. The duration of the remission status was also verified by medical record review. The increase in SLE organ damage (SDI) score since 5 years prior to recruitment was compared between patients who were and were not in clinical remission for at least 5 years. Participants were randomly selected for assessment of quality of life by using both the validated version of SF36 and the LupusPRO (version 1.8) and comparison was made between those who did and did not achieve clinical remission for ≥5 years by the independent Students’ t-test.
To cite this abstract in AMA style:Mok CC, Ho LY, Tse SM, Chan KL. Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/effect-of-disease-remission-on-organ-damage-and-quality-of-life-in-chinese-patients-with-systemic-lupus-erythematosus/. Accessed December 2, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-disease-remission-on-organ-damage-and-quality-of-life-in-chinese-patients-with-systemic-lupus-erythematosus/